-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Moderna (MRNA) as Drastic Change to COVID-19 Vaccine Access Appears Unlikely
-
-
-
-
-
-
-
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
-
-
-
-
-
-
-
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
-
-
-
-
-
-
-
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
-
-
-
-
-
-
-
FDA Authorizes Moderna (MRNA) and Pfizer (PFE) -BioNTech (BNTX) COVID-19 Vaccines for Children Down to 6 Months of Age
-
-
-
-
-
-
-
Coronavirus (COVID-19) Update: FDA Expands Eligibility for COVID-19 Vaccine Boosters
-
-
-
-
-
-
-
U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost
-
15,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

